Nevirapine and tuberculosis predict first-line treatment failure in HIV patients in Indonesia: Case-control study
- PMID: 33133585
- PMCID: PMC7584999
- DOI: 10.1016/j.amsu.2020.10.005
Nevirapine and tuberculosis predict first-line treatment failure in HIV patients in Indonesia: Case-control study
Abstract
Introduction: Indonesia antiretroviral therapy guideline suggests the use of Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)-based regiments as first line of HIV treatment and Protease Inhibitor to replace NNRTI when treatment failure occurred. This case-control study was aimed to study factors predicting first-line ART treatment failure among HIV positive patients aged >15 years, non-pregnant, and registered in our institution, Indonesia.
Methods: Diagnosis of HIV treatment failure was made according to the standard WHO criteria. Demographic and outcome variables were recorded. The association between variables were analyzed by Chi-square test with odds ratios (OR) and 95% confidence intervals (95% CI), followed by multivariate analysis using logistic regression test.
Results: Twenty-six index cases and 26 age- and sex-matched control cases were included in the study with a mean age of 32.27 ± 8.7 years and 32.88 ± 8.15 years, respectively. Median time for switching to second-line (Lopinavir/ritonavir, LPV/r) was 46.32 ± 30.21 months. Patients presented with tuberculosis and treated by nevirapine as the first-line treatment were 26.6-folds (95% CI: 2.41-293.81, p = 0.007) and 6.7-folds (95% CI: 1.56-28.45, p = 0.011) higher risk for treatment failure, respectively.
Conclusions: The presence of tuberculosis and the use of nevirapine in first-line treatment were strong predictors for first-line ARV treatment failure, suggesting for closer clinical monitoring for patients with those conditions. A further and larger prospective cohort study is needed to confirm the findings in this study.
Keywords: ART treatment failure; HIV; Indonesia; Nevirapine; Predicting factors; Tuberculosis.
© 2020 The Authors. Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd.
Conflict of interest statement
The authors declared no potential conflicts of interest.
References
-
- Who . 2013 June. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach June 2013. - PubMed
-
- UNAIDS . e; 2018. Miles to go: closing gaps, breaking barrier, righting justic.https://www.unaids.org/sites/default/files/media_asset/miles-to-go_en.pdf Available from:
-
- Agha R., Abdall-Razak A., Crossley E., Dowlut N., Iosifidis C., Mathew G. STROCSS 2019 Guideline: strengthening the reporting of cohort studies in surgery. Int. J. Surg. 2019;72:156–165. - PubMed
LinkOut - more resources
Full Text Sources
